We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

7974:TSENintendo Co., Ltd. Analysis

Data as of 2026-06-01 - not real-time

¥7,163.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Nintendo’s share price sits at ¥7,163, well below its 20‑day SMA of ¥7,249 and the longer‑term 50‑day and 200‑day averages, confirming a bearish technical backdrop. The RSI of ~41 suggests the stock is not yet oversold, while the MACD histogram is modestly positive, hinting at a potential short‑term rebound. Volume has been trending downwards, raising a mild liquidity concern despite the ¥8.3 trillion market cap. The 30‑day volatility of 44 % and a max drawdown of over 53 % underscore the price’s historical swing potential. On the valuation side, the DCF‑derived fair value of ¥10,641 implies roughly a 48 % upside, positioning the stock as undervalued relative to its intrinsic worth. However, the trailing P/E of 19.6 sits above the industry average of 17.1, reflecting a premium that the market has not yet justified.
The company boasts a robust balance sheet with ¥2.2 trillion in cash, zero debt, and a healthy payout ratio of 60 % supporting a sustainable 3.06 % dividend. Revenue surged by 95 % year‑over‑year and margins remain solid (gross 39 %, operating 14.7 %, profit 18.3 %). Return on equity of 15 % and free cash flow exceeding ¥277 billion illustrate strong cash‑generation capability. The strategic rollout of the higher‑priced Switch 2 is expected to reinforce the growth trajectory while leveraging Nintendo’s iconic IP portfolio. Given the blend of growth momentum and attractive valuation, the medium‑ and long‑term outlook is bullish, though short‑term traders should respect the current bearish technical signals. Investors seeking exposure should consider a phased approach: hold or trim exposure now, then accumulate as the price tests support and moves toward its intrinsic target.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below key moving averages
  • Decreasing volume
  • Bearish trend direction

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF upside of ~48%
  • Strong cash flow and zero debt
  • Sustainable dividend yield

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Robust IP pipeline and Switch 2 launch
  • High ROE and profit margins
  • Long‑term cash generation and low leverage

Key Metrics & Analysis

Financial Health

Revenue Growth95.10%
Profit Margin18.33%
P/E Ratio19.6
ROE14.93%
ROA6.25%
P/B Ratio2.8
Op. Cash Flow¥289.8B
Free Cash Flow¥277.4B
Industry P/E17.1

Technical Analysis

TrendBearish
RSI40.9
Support¥6,849.00
Resistance¥7,984.00
MA 20¥7,248.45
MA 50¥8,127.04
MA 200¥10,896.92
MACDBullish
VolumeDecreasing
Fear & Greed Index93.29

Valuation

Fair Value¥10,641.12
Target Price¥10,641.07
Upside/Downside48.56%
GradeUndervalued
TypeBlend
Dividend Yield3.06%

Risk Assessment

Beta0.25
Volatility43.87%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.